{
  "main_header": {
    "sid": 525226,
    "name": "Indrayani Biotec",
    "stock_name": "Indrayani Biotec",
    "full_name": "Indrayani Biotech Ltd",
    "name_url": "stocks-analysis/indrayani-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.13",
    "chg": -0.45,
    "chgp": "-4.7%",
    "dir": -1,
    "prev_price": "9.58",
    "mcapval": "74.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526445,
    "symbol": "",
    "ind_name": "Other Agricultural Products",
    "ind_code": 101,
    "indexname": "India SENSEX",
    "isin": "INE007C01021",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "36.45 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/indrayani-biotec-525226-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 9,
    "sid": "525226",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/indrayani-biotech-525226"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Oct-2026",
      "details": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulation 2018 for the quarter ended 30th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Results-Unaudited Standalone & Consolidated Financial Results For Quarter Ended June 30 2026 Along With Limited Review Report.",
      "datetime": "07-Oct-2026",
      "details": "Unaudited Standalone & Consolidated Financial Results for quarter ended June 30 2026 along with Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report.",
      "datetime": "07-Oct-2026",
      "details": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30th June 2026 Along With Limited Review Report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Indrayani Biotech Ltd has announced <strong>5:7</strong> rights issue, ex-date: 28 Apr 26",
          "dt": "2026-04-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News